APA (7th ed.) Citation

Qasim, B., Kumari, H., Kashif, S. N., Abbas, S. M. I., Hani, O., Salma, O., . . . Ameen, T. B. (2025). Evolving paradigms in primary biliary cholangitis: From molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond. Egyptian Liver Journal, 15(1), 1. https://doi.org/10.1186/s43066-025-00464-6

Chicago Style (17th ed.) Citation

Qasim, Bushra, et al. "Evolving Paradigms in Primary Biliary Cholangitis: From Molecular Mechanisms to Personalized Therapeutics with Seladelpar, Elafibranor, and Beyond." Egyptian Liver Journal 15, no. 1 (2025): 1. https://doi.org/10.1186/s43066-025-00464-6.

MLA (9th ed.) Citation

Qasim, Bushra, et al. "Evolving Paradigms in Primary Biliary Cholangitis: From Molecular Mechanisms to Personalized Therapeutics with Seladelpar, Elafibranor, and Beyond." Egyptian Liver Journal, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1186/s43066-025-00464-6.